Cargando…

Hospital Resources Used for Ectopic Pregnancy Treatment by Laparoscopy and Methotrexate

OBJECTIVE: To compare resources used in the medical and laparoscopic treatment of unruptured ectopic pregnancy. METHODS: We prospectively recorded all the medical resources required in the treatment of unruptured ectopic pregnancy. The study period ranged from January 1, 1995 to June 30, 1998. Singl...

Descripción completa

Detalles Bibliográficos
Autores principales: Lecuru, Fabrice, Camatte, Sophie, Viens-Bitker, Catherine, Chasset, Sophie, Leonard, Franck, Taurelle, Roland
Formato: Texto
Lenguaje:English
Publicado: Society of Laparoendoscopic Surgeons 2001
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3015437/
https://www.ncbi.nlm.nih.gov/pubmed/11394423
_version_ 1782195513736560640
author Lecuru, Fabrice
Camatte, Sophie
Viens-Bitker, Catherine
Chasset, Sophie
Leonard, Franck
Taurelle, Roland
author_facet Lecuru, Fabrice
Camatte, Sophie
Viens-Bitker, Catherine
Chasset, Sophie
Leonard, Franck
Taurelle, Roland
author_sort Lecuru, Fabrice
collection PubMed
description OBJECTIVE: To compare resources used in the medical and laparoscopic treatment of unruptured ectopic pregnancy. METHODS: We prospectively recorded all the medical resources required in the treatment of unruptured ectopic pregnancy. The study period ranged from January 1, 1995 to June 30, 1998. Single-dose intramuscular methotrexate injections were administered in 55 women (group I). This therapeutic option was provided on an outpatient basis in small EP (β-HCG level < 5000 IU/L and hematosalpinx diameter < 3 cm). Serial clinical controls and biologic tests were performed until bHCG became negative. Forty women underwent a laparoscopic salpingostomy because they refused the methotrexate regimen or had “social” contra-indications (ie, predictable difficulties in the follow-up) (group II). Twenty-one patients underwent conservative laparoscopic treatment because of “medical” contraindications to methotrexate (group III). We recorded the resources used with the outpatient and inpatient treatment in each group (methotrexate consumption, operating room acts, length of hospital stay, clinical examinations, biological tests, and sonograms during the follow-up). RESULTS: We observed similar cure rates in each group, but it took significantly longer for β-HCG to become negative in group 1. However, hospitalization was significantly less often required, and the length of hospital stay was shorter in this group. But length of follow-up, number of office visits, biological tests, sonograms, and subsequent readmissions were significantly more frequent after methotrexate. Despite more severe clinical presentations for patients in group III, we didn't find any significant differences in the hospital resources used in this group in comparison with those used in group II. CONCLUSIONS: The outpatient methotrexate option may result in low consumption of resources for a hospital because most of the follow-up can be performed by city practitioners and laboratories. For the laparoscopic option, efforts should be made to reduce the postoperative hospital stay.
format Text
id pubmed-3015437
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher Society of Laparoendoscopic Surgeons
record_format MEDLINE/PubMed
spelling pubmed-30154372011-02-17 Hospital Resources Used for Ectopic Pregnancy Treatment by Laparoscopy and Methotrexate Lecuru, Fabrice Camatte, Sophie Viens-Bitker, Catherine Chasset, Sophie Leonard, Franck Taurelle, Roland JSLS Scientific Papers OBJECTIVE: To compare resources used in the medical and laparoscopic treatment of unruptured ectopic pregnancy. METHODS: We prospectively recorded all the medical resources required in the treatment of unruptured ectopic pregnancy. The study period ranged from January 1, 1995 to June 30, 1998. Single-dose intramuscular methotrexate injections were administered in 55 women (group I). This therapeutic option was provided on an outpatient basis in small EP (β-HCG level < 5000 IU/L and hematosalpinx diameter < 3 cm). Serial clinical controls and biologic tests were performed until bHCG became negative. Forty women underwent a laparoscopic salpingostomy because they refused the methotrexate regimen or had “social” contra-indications (ie, predictable difficulties in the follow-up) (group II). Twenty-one patients underwent conservative laparoscopic treatment because of “medical” contraindications to methotrexate (group III). We recorded the resources used with the outpatient and inpatient treatment in each group (methotrexate consumption, operating room acts, length of hospital stay, clinical examinations, biological tests, and sonograms during the follow-up). RESULTS: We observed similar cure rates in each group, but it took significantly longer for β-HCG to become negative in group 1. However, hospitalization was significantly less often required, and the length of hospital stay was shorter in this group. But length of follow-up, number of office visits, biological tests, sonograms, and subsequent readmissions were significantly more frequent after methotrexate. Despite more severe clinical presentations for patients in group III, we didn't find any significant differences in the hospital resources used in this group in comparison with those used in group II. CONCLUSIONS: The outpatient methotrexate option may result in low consumption of resources for a hospital because most of the follow-up can be performed by city practitioners and laboratories. For the laparoscopic option, efforts should be made to reduce the postoperative hospital stay. Society of Laparoendoscopic Surgeons 2001 /pmc/articles/PMC3015437/ /pubmed/11394423 Text en © 2001 by JSLS, Journal of the Society of Laparoendoscopic Surgeons. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits for noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited and is not altered in any way.
spellingShingle Scientific Papers
Lecuru, Fabrice
Camatte, Sophie
Viens-Bitker, Catherine
Chasset, Sophie
Leonard, Franck
Taurelle, Roland
Hospital Resources Used for Ectopic Pregnancy Treatment by Laparoscopy and Methotrexate
title Hospital Resources Used for Ectopic Pregnancy Treatment by Laparoscopy and Methotrexate
title_full Hospital Resources Used for Ectopic Pregnancy Treatment by Laparoscopy and Methotrexate
title_fullStr Hospital Resources Used for Ectopic Pregnancy Treatment by Laparoscopy and Methotrexate
title_full_unstemmed Hospital Resources Used for Ectopic Pregnancy Treatment by Laparoscopy and Methotrexate
title_short Hospital Resources Used for Ectopic Pregnancy Treatment by Laparoscopy and Methotrexate
title_sort hospital resources used for ectopic pregnancy treatment by laparoscopy and methotrexate
topic Scientific Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3015437/
https://www.ncbi.nlm.nih.gov/pubmed/11394423
work_keys_str_mv AT lecurufabrice hospitalresourcesusedforectopicpregnancytreatmentbylaparoscopyandmethotrexate
AT camattesophie hospitalresourcesusedforectopicpregnancytreatmentbylaparoscopyandmethotrexate
AT viensbitkercatherine hospitalresourcesusedforectopicpregnancytreatmentbylaparoscopyandmethotrexate
AT chassetsophie hospitalresourcesusedforectopicpregnancytreatmentbylaparoscopyandmethotrexate
AT leonardfranck hospitalresourcesusedforectopicpregnancytreatmentbylaparoscopyandmethotrexate
AT taurelleroland hospitalresourcesusedforectopicpregnancytreatmentbylaparoscopyandmethotrexate